NuVasive Investor Relations

NuVasive is a world leader in minimally invasive, procedurally integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes.

Press Release

NuVasive to Report Third Quarter 2004 Financial Results on October 26, 2004

SAN DIEGO, Sept. 27 /PRNewswire-FirstCall/-- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that it will release third quarter financial results for the period ended September 30, 2004 after market close on Tuesday, October 26, 2004 with an accompanying conference call at 5:00 p.m. EDT / 2:00 p.m. PDT.

A live Web cast of the conference call will be available online from the investor relations page of the Company's corporate Web site at The dial-in numbers are (800) 247-9979 for domestic callers, and (973) 409-9254 for international. The reservation number for both is 5220349. After the live Web cast, the call will remain available on NuVasive's Web site,, through November 26, 2004. In addition, a telephonic replay of the call will be available until November 9, 2004. The replay dial-in numbers are (877) 519-4471 for domestic callers and (973) 341-3080 for international callers. Please use reservation code 5220349.

About NuVasive

NuVasive is a medical device company focusing on the design, development and marketing of products for use in minimally disruptive surgical treatments for the spine. NuVasive's Maximum Access Surgery (MAS(TM)) product platform includes the NeuroVision(R) nerve avoidance system, MaXcess(TM) spine access system, and specialized implants. NuVasive also offers classic fusion implant products for use in spine surgery and has a robust R&D pipeline emphasizing motion preservation products such as total disc replacement (TDR).

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:

Statements in this press release regarding NuVasive, Inc.'s business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. For example, the timing of the closing of this offering could vary based upon the timing of the satisfaction of the closing conditions contained in the underwriting agreement relating to the offering. Actual results, performance or achievements could differ materially from the Company's current expectations. NuVasive undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Kevin C. O'Boyle
Chief Financial Officer
NuVasive, Inc.

Stephanie Carrington/Greg Tiberend
The Ruth Group
SOURCE NuVasive, Inc.
-0- 09/27/2004
/Web site:

09/27/2004 11:18 EDT